Company: TBPH
Filing Date: 2025-04-10
Form Type: DEF 14A
Source: 0001104659-25-033819
Chunk: 34

Company: Theravance Biopharma, Inc.
Filing Date: 2025-04-10
Form: DEF 14A
Chunk 34
---
 11 | ​ | ​ |     1 | ​ | ​ |    2 | ​ | ​ |     2 | ​ | ​ |       11 | ​ | ​ |       10 | ​ | ​ |           5 | ​ |
| Year Joined          | ​ | ​ |       2013 | ​ | ​ |  2018 | ​ | ​ |   2014 | ​ | ​ |  2023 | ​ | ​ | 2023 | ​ | ​ |  2023 | ​ | ​ |     2014 | ​ | ​ |     2015 | ​ | ​ |        2020 | ​ |

Compensation Committee Interlocks and Insider Participation As noted above, the compensation committee of our board of directors is currently comprised of Messrs. Broshy, Grant, Mitchell and O’Connor. None of the members of our compensation committee was at any time during the year ended December 31, 2024 (or at any other time) an officer or employee of Theravance Biopharma. None of our executive officers serve, or served during the year ended December 31, 2024, as a member of the board of directors or compensation committee of any other entity that has or has had one or more executive officers serving as a member of our board of directors or our compensation committee. Meetings of the Board of Directors The full board of directors met 11 times during the year ended December 31, 2024 and acted by unanimous written consent twice. During the year ended December 31, 2024, no director attended fewer than 75% of the aggregate of (i) the total number of meetings of the board of directors (held during the period they were a director) and (ii) the total number of meetings held by all committees of the board on which they served (held during the period they were a member). It is our policy that directors are invited and encouraged to attend our annual general meetings, and all of our directors attended the 2024 Annual Meeting. Board Oversight of Risk One of the key functions of our board of directors is informed oversight of our risk management process. In particular, our board of directors is responsible for monitoring and assessing strategic risk exposure. Our executive officers are responsible for the day-to-day management of the material risks we face. While our board of directors is ultimately responsible for risk oversight, our board committees assist the board in fulfilling its oversight responsibilities in certain areas of risk. The audit committee